Evidence map›Paper›PMID 37425008›Full record

ArticleFrontiers in neuroscience2023

SENECA: building a fully digital neuromorphic processor, design trade-offs and challenges.

Guangzhi Tang, Kanishkan Vadivel, Yingfu Xu, Refik Bilgic, Kevin Shidqi, Paul Detterer, Stefano Traferro, Mario Konijnenburg, Manolis Sifalakis, Gert-Jan van Schaik and 1 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Guangzhi TangImec, Eindhoven, Netherlands.
Kanishkan VadivelImec, Eindhoven, Netherlands.
Yingfu XuImec, Eindhoven, Netherlands.
Refik BilgicImec, Leuven, Belgium.
Kevin ShidqiImec, Eindhoven, Netherlands.
Paul DettererImec, Eindhoven, Netherlands.
Stefano TraferroImec, Eindhoven, Netherlands.
Mario KonijnenburgImec, Eindhoven, Netherlands.
Manolis SifalakisImec, Eindhoven, Netherlands.
Gert-Jan van SchaikImec, Eindhoven, Netherlands.
Amirreza YousefzadehImec, Eindhoven, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuromorphic processors aim to emulate the biological principles of the brain to achieve high efficiency with low power consumption. However, the lack of flexibility in most neuromorphic architecture designs results in significant performance loss and inefficient memory usage when mapping various neural network algorithms. This paper proposes SENECA, a digital neuromorphic architecture that balances the trade-offs between flexibility and efficiency using a hierarchical-controlling system. A SENECA core contains two controllers, a flexible controller (RISC-V) and an optimized controller (Loop Buffer). This flexible computational pipeline allows for deploying efficient mapping for various neural networks, on-device learning, and pre-post processing algorithms. The hierarchical-controlling system introduced in SENECA makes it one of the most efficient neuromorphic processors, along with a higher level of programmability. This paper discusses the trade-offs in digital neuromorphic processor design, explains the SENECA architecture, and provides detailed experimental results when deploying various algorithms on the SENECA platform. The experimental results show that the proposed architecture improves energy and area efficiency and illustrates the effect of various trade-offs in algorithm design. A SENECA core consumes 0.47 mm

Indexed as

AI acceleratorarchitectural explorationbio-inspired processingevent-based neuromorphic processorSENECAspiking neural network

Identifiers

PMID37425008
PMCPMC10326429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.